Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Ebola Virus Disease Features Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in the Rhesus Macaque Model
  2. Liu, David X; Pahar, Bapi; Cooper, Timothy K; Perry, Donna L; Xu, Huanbin; Huzella, Louis M; Adams, Ricky D; Hischak, Amanda M W; Hart, Randy J; Bernbaum, Rebecca; Rivera, Deja; Anthony, Scott; St Claire, Marisa; Byrum, Russell; Cooper, Kurt; Reeder, Rebecca; Kurtz, Jonathan; Hadley, Kyra; Wada, Jiro; Crozier,Ian; Worwa, Gabriella; Bennett, Richard S; Warren, Travis; Holbrook, Michael R; Schmaljohn, Connie S; Hensley, Lisa E
  3. The Journal of Infectious Diseases. 2023, Jun 04;
  1. 2.   Co-expression of TNFR2 and CD25 identifies more of the functional CD4(+)FOXP3(+) regulatory T cells in human peripheral blood
  2. Chen, X.; Subleski, J. J.; Hamano, R.; Howard, O. M. Z.; Wiltrout, R. H.; Oppenheim, J. J.
  3. European Journal of Immunology. 2010, Apr; 40(4): 1099-1106.
  1. 3.   Preclinical Evaluation of an Anti-CD25 Monoclonal Antibody, 7G7/B6, Armed with the beta-Emitter, Yttrium-90, as a Radioimmunotherapeutic Agent for Treating Lymphoma
  2. Zhang, M. L.; Yao, Z. S.; Garmestani, K.; Yu, S.; Goldman, C. K.; Paik, C. H.; Brechbiel, M. W.; Carrasquillo, J. A.; Waldmann, T. A.
  3. Cancer Biotherapy and Radiopharmaceuticals. 2009 24(3): 303-309.
  1. 4.   Expression of TNFR2 defines a maximally suppressive subset of mouse CD4(+)CD25(+)FoxP3(+) T regulatory cells: Applicability to tumor-infiltrating T regulatory cells
  2. Chen, X.; Subleski, J. J.; Kopf, H.; Howard, O.; Mannel, D. N.; Oppenheim, J. J.
  3. Journal of Immunology. 2008 180(10): 6467-6471.
  1. 5.   The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells
  2. Wuest, T. Y.; Willette-Brown, J.; Durum, S. K.; Hurwitz, A. A.
  3. Journal of Leukocyte Biology. 2008 84(4): 973-980.
  1. 6.   Decreased CD127 expression on T cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy
  2. Read, S. W.; Higgins, J.; Metcalf, J. A.; Stevens, R. A.; Rupert, A.; Nason, M. C.; Lane, H. C.; Sereti, I.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2006, Aug; 42(5): 537-544.
  1. 7.   Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE
  2. Chen, X.; Oppenheim, J. J.; Winkler-Pickett, R. T.; Ortaldo, J. R.; Howard, O. M. Z.
  3. European Journal of Immunology. 2006, Aug; 36(8): 2139-2149.
  1. 8.   Pertussis toxin as an adjuvant suppresses the number and function of CD4(+)CD25(+) T regulatory cells
  2. Chen, X.; Winkler-Pickett, R. T.; Carbonetti, N. H.; Ortaldo, J. R.; Oppenheim, J. J.; Howard, O. M. Z.
  3. European Journal of Immunology. 2006, Mar; 36(3): 671-680.
  1. 9.   CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2
  2. Tai, X. G.; Cowan, M.; Feigenbaum, L.; Singer, A.
  3. Nature Immunology. 2005, FEB; 6(2): 152-162.
  1. 10.   Differential response of murine CD4(+)CD25(+) and CD4(+)CD25(-) T cells to dexamethasone-induced cell death
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, D. M. Z.
  3. European Journal of Immunology. 2004 34(3): 859-869.
  1. 11.   Effects of IL-7 and dexamethasone: Induction of CD25, the high affinity IL-2 receptor, on human CD4(+) cells
  2. Chung, I. Y.; Dong, H. F.; Zhang, X.; Hassanein, N. M. A.; Howard, O. M. Z.; Oppenheim, J. J.; Chen, X.
  3. Cellular Immunology. 2004, NOV-DEC; 232(1-2): 57-63.
  1. 12.   Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis
  2. Kullberg, M. C.; Jankovic, D.; Gorelick, P. L.; Caspar, P.; Letterio, J. J.; Cheever, A. W.; Sher, A.
  3. Journal of Experimental Medicine. 2002 196(4): 505-515.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel